Clinical trial Recruiting at 1 site Observational

Registry for patients with otoferlin-related hearing impairment

Official title: Patient Registry for Individuals With Otoferlin-Associated Hearing Loss

Run by University Medical Center Goettingen · NCT05946057 · Data updated 2026-11-12

This study is collecting information from people with otoferlin-related hearing loss to better understand the condition and help improve future treatments.

Quick facts

Study typeObservational
SexAll
Enrollment100 (estimated)
SponsorUniversity Medical Center Goettingen
Academic / other
Locations1 site (Goettigen, Lower Saxony)
StatusRecruiting
StartedFebruary 21, 2023
Main results expectedFebruary 21, 2048
Study endsFebruary 21, 2048
Registry record updatedMay 28, 2025
Trial IDNCT05946057 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with a confirmed molecular genetic diagnosis of otoferlin-related hearing impairment.

Probably not a fit

Patients with hearing impairment due to non-otoferlin genetic causes will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects detailed information about individuals diagnosed with otoferlin-related auditory synaptopathy and hearing impairment. It aims to gather molecular genetic data and clinical information to support a natural history study of the condition. Conducted in both German and English, the study follows ethical guidelines and has received approval from the University Medical Center Göttingen's Ethics Committee. The primary goal is to enhance understanding of the condition and facilitate future research and tailored therapies.

Why it matters

Potential benefit: If successful, this registry could lead to improved diagnosis and personalized treatment options for patients with otoferlin-related hearing impairment.

How similar studies have gone: While this approach is focused on a specific genetic condition, similar registries have successfully advanced understanding and treatment of other hereditary conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A molecular genetic diagnosis involving biallelic variants in otoferlin (OTOF) and audiometry

Exclusion Criteria:

* Patients with evidence of non-OTOF molecular genetic diagnoses

Where it's running

  • University Medical Center Goettingen
    Goettigen, Lower Saxony, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.